Edwards Lifesciences announced that the SAPIEN 3 Ultra system has received US Food and Drug Administration approval for transcatheter aortic valve replacement in severe, symptomatic aortic stenosis patients who are determined to be at intermediate or greater risk of open-heart surgery.
This site is not optimized for Internet Explorer 8 (or older).
Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.
January 4, 2019
Clinical Leaflet Thrombosis in Transcatheter and Surgical Bioprosthetic Aortic Valves by Four-Dimensional Computed Tomography
December 10, 2018
Basra and colleagues report that among patients with bioprosthetic aortic valves who had clinical or echocardiographic indications suggestive of leaflet thrombosis, one-third of patients had this diagnosis confirmed by four-dimensional computed tomography (4DCT).
December 5, 2018
Coyan and colleagues report outcomes following double valve surgery in a cohort of patients who underwent operation between 2011 and 2017.
December 5, 2018
Using remodeling aortic and mitral annuloplasty rings, a double valve repair was accomplished in a young patient with Marfan syndrome.
November 13, 2018
In this paper, Dr Svensson covers his technique of leaflet repair during aortic root reimplantation. The core technical points are described as well as the long-term clinical outcomes.
November 9, 2018
A multidisciplinary team led by Bob Kiaii at the London Health Sciences Centre in Ontario, Canada, has reportedly completed the world's first robotic performance of a specific aortic valve replacement procedure in a patient with aorti
October 25, 2018
Olaf Wendler of King's College Hospital in London, UK, presents a discussion on the 2017 ESC/EACTS guidelines for the management of valvular heart disease.
Supra-Annular Versus Intra-Annular Prostheses in Aortic Valve Replacement: Impact on Hemodynamics and Clinical Outcomes
October 23, 2018
Kim and colleagues sought to determine if a supra-annular aortic valve prosthesis implantation is superior to an intra-annular implantation. The authors retrospectively reviewed outcomes and echocardiographic data for 587 patients who received either supra-annular or intra-annular aortic valve prostheses from St Jude Medical.
October 17, 2018
Find it here: the 32nd EACTS Annual Meeting in Milan, Italy
Predicting Quality of Life at 1 Year After Transcatheter Aortic Valve Replacement in a Real-World Population
October 14, 2018
Despite the benefit for most patients, some patients have poor outcome after transcatheter aortic valve implantation (TAVI). Currently it is hard to predict which patient is predisposed to poor outcome at one year. This paper investigates the performance of a previously developed prediction model of poor outcome after TAVI.